The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID 19 update

25 Mar 2020 14:40

RNS Number : 6007H
Polypipe Group PLC
25 March 2020
 

25 March 2020

 

Polypipe Group plc

 

COVID 19 update

 

Polypipe Group plc ("Polypipe", the "Company" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment, today provides the following COVID 19 update.

Employees, customers and operations

The health, safety and wellbeing of our people has always been, and continues to be, at the forefront of everything we do. The Group and its leadership team has a duty of care to its employees and customers, and the evaluation of risk and taking mitigating actions to protect those employees and customers is taken very seriously and is very much ingrained in our culture. In light of recent events and until further notice, we have decided to wind down our operations to that which is absolutely necessary to support the Government in its battle with COVID 19 and keep the economy going. These include the following:

· Parts of the Group supporting the National Health Service in very specific roles in increasing capabilities to cope with the inevitable increase in COVID 19 patients. Our Nuaire business is manufacturing ventilation for the Royal Marsden Hospital and is receiving urgent enquiries from many other NHS sites for this as well as other essential projects.

· Our Building Products business has been requested to manufacture special pipe for emergency medical use.

· On a wider front, it is necessary to keep supplying some of our plumbing and drainage products that are needed for urgent repair and maintenance across the country to keep essential projects and services running.

The reduction in our operations will happen over the next few days as, for operational reasons, it is not something that can be done immediately.

Current trading and FY20 guidance

Trading for the year to date has been in line with expectations, with no material impact on performance from the COVID 19 pandemic so far. However, the decision to wind down operations, and the inevitable but as yet unquantifiable wider impact of COVID 19 on our end markets in the next weeks and months means it is no longer possible to provide financial guidance for the year ending 31 December 2020 and beyond. Guidance will be resumed when a degree of normality returns to our markets.

Focus on cash preservation and withdrawal of FY19 final dividend

It is clear that both revenues and profits will be adversely impacted in the coming months by the decision to wind down operations and by the effect of COVID 19 on our end markets. In response, we have implemented a range of measures to reduce costs and conserve cash during this period, including utilisation of the Job Retention Scheme and other measures announced by the Government.

Whilst the Board recognises the importance of the dividend to shareholders, as part of its cash conservation plans, the Board has decided to withdraw its recommendation to pay a final dividend of 8.1 pence per share on 28 May 2020, and this will not now be put to shareholders at the AGM on 21 May 2020. This decision will ensure £16m cash will be retained in the business that would otherwise have been distributed which the Board believes is prudent and appropriate in the current circumstances.

The Group enters this period of uncertainty with a strong balance sheet and good liquidity. Excluding IFRS16, net debt at 31 December 2019 stood at £150.0m, representing 1.5 times EBITDA on a pre IFRS16 basis. The Group has a £300m Revolving Credit Facility, committed through to November 2023, and has taken pre-emptive action in drawing down all but £15m of the unutilised facility and holds it on deposit across several banks.

Commenting on this announcement, Martin Payne, Chief Executive Officer, said "In these unprecedented times we have acted swiftly and decisively, taking our decisions with the best interests of our employees and customers foremost in our minds. The Board's thoughts are with all of our employees and their families in what are worrying times for us all. The Group's strong balance sheet and cash generation, together with our talented people and clear strategy gives the Board confidence that it will overcome whatever challenges await."

 

Enquiries:

 

Polypipe

Martin Payne, Chief Executive Officer

Paul James, Chief Financial Officer

 

+44 (0) 1709 770 000

Brunswick

Nina Coad

Dan Roberts

Sophia Lazarus

 

+44 (0) 20 7404 5959

Notes to Editors:

Polypipe Group plc ("Polypipe", the "Company" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment is the largest manufacturer in the UK, and among the ten largest manufacturers in Europe, of plastic piping systems for the residential, commercial, civils and infrastructure sectors by revenue. It is also a leading designer and manufacturer of energy efficient ventilation systems in the UK.

The Group operates from 19 facilities in total, and with over 20,000 product lines, manufactures the UK's widest range of plastic piping systems for heating, plumbing, drainage and ventilation. The Group primarily targets the UK and European building and construction markets with a presence in Italy, the Netherlands, Ireland and the Middle East and sales to specific niches in the rest of the world.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUVOSRRKUOUAR
Date   Source Headline
6th Apr 20213:30 pmRNSChange of Name
16th Mar 20217:00 amRNSFinal Results
11th Mar 20213:17 pmRNSHolding(s) in Company
5th Mar 20214:17 pmRNSHolding(s) in Company
3rd Mar 20219:24 amRNSHolding(s) in Company
26th Feb 20215:21 pmRNSHolding(s) in Company
26th Feb 20214:58 pmRNSTotal Voting Rights
17th Feb 20218:05 amRNSHolding(s) in Company
15th Feb 20214:22 pmRNSDirector/PDMR Shareholding
15th Feb 20211:59 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSResults of placing
10th Feb 20214:52 pmRNSProposed placing of new ordinary shares
10th Feb 20214:50 pmRNSAcquisition of ADEY
2nd Feb 20217:00 amRNSAcquisition of Nu-Heat and Trading Update
1st Feb 20213:57 pmRNSHolding(s) in Company
29th Jan 20215:32 pmRNSHolding(s) in Company
8th Jan 20218:50 amRNSHolding(s) in Company
14th Dec 20207:00 amRNSTrading Update
24th Nov 20208:25 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSTrading Update
2nd Nov 20202:31 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:05 amRNSBlock listing Interim Review
30th Oct 20204:26 pmRNSTotal Voting Rights
29th Oct 20202:32 pmRNSDirector/PDMR Shareholding
19th Oct 202010:09 amRNSHolding(s) in Company
7th Oct 202012:28 pmRNSHolding(s) in Company
6th Oct 202010:19 amRNSHolding(s) in Company
23rd Sep 202010:43 amRNSDirector Declaration
22nd Sep 20203:59 pmRNSDirector/PDMR Shareholding
17th Sep 20204:21 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSHalf-year Report
17th Jul 20204:26 pmRNSNon-Executive Director update
16th Jul 20209:37 amRNSHolding(s) in Company
7th Jul 20207:00 amRNSCOVID-19 Update
30th Jun 20202:41 pmRNSTotal Voting Rights
29th Jun 202012:59 pmRNSDirector Declaration
26th Jun 20204:19 pmRNSDirector/PDMR Shareholding
23rd Jun 20202:57 pmRNSDirector/PDMR Shareholding
23rd Jun 20208:28 amRNSHolding(s) in Company
22nd Jun 20204:14 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
22nd Jun 20203:06 pmRNSNon-Executive Director changes
18th Jun 20204:14 pmRNSDirector/PDMR Shareholding
17th Jun 20208:18 amRNSHolding(s) in Company
3rd Jun 202011:17 amRNSHolding(s) in Company
1st Jun 20201:24 pmRNSTotal Voting Rights
21st May 20203:05 pmRNSResult of AGM
15th May 202012:55 pmRNSHolding(s) in Company
13th May 202010:14 amRNSDirector/PDMR Shareholding
12th May 20204:01 pmRNSAnnual General Meeting 2020 - Change of Venue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.